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in the Loss of Phospholipase and Hemolytic Activities and
Pathogenicity for Turbot (Scophthalmus maximus)
Boguang Sun,1 Xiao-Hua Zhang,1* Xuexi Tang,1 Shushan Wang,1 Yingbin Zhong,1
Jixiang Chen,1 and Brian Austin2
Department of Marine Biology, Ocean University of China, Qingdao, China,1 and School of Life Sciences,
Heriot-Watt University, Edinburgh EH14 4AS, United Kingdom2
Received 25 October 2006/Accepted 10 January 2007
Vibrio harveyi hemolysin, an important virulence determinant in fish pathogenesis, was further character-
ized, and the enzyme was identified as a phospholipase B by gas chromatography. Site-directed mutagenesis
revealed that a specific residue, Ser153, was critical for its enzymatic activity and for its virulence in fish.
Vibrio harveyi is a serious pathogen for many marine verte-
brates and invertebrates (3, 4, 8). Extracellular products and, in
particular, hemolysin have been considered to be important for
virulence (4, 23). Hemolysin is arguably the most widely dis-
tributed exotoxin among pathogenic vibrios, and there is much
epidemiological and experimental evidence to suggest involve-
ment in disease pathogenesis (8, 19, 24). Although generally
referred to as hemolysins for their capacity to lyse erythrocytes,
these toxins correspond to two different modes of action, in-
volving either a pore-forming protein or a phospholipase en-
zyme (17). Hemolysis may result from the phospholipase en-
zyme activity demonstrated by some species of bacteria,
including phospholipase C of Pseudomonas aeruginosa and
phospholipase D in Photobacterium damselae subspecies dam-
selae. However, most other hemolysins act as pore-forming
proteins (8, 9, 15). Hemolysin with both of these activities has
also been reported (14).
Zhang et al. (25) cloned and sequenced two closely related
hemolysin genes from a highly pathogenic isolate, V. harveyi
VIB 645. Both of the genes (designated vhhA and vhhB) had
an open reading frame of 1,254 nucleotides, which is the same
size as that of the tlh gene of Vibrio parahaemolyticus (13).
Furthermore, nucleotide sequence alignment revealed that the
identities of vhhA and vhhB to tlh were 77.5% and 77.2%,
respectively (25). Thermolabile hemolysin (TLH) of V. parah-
aemolyticus, also named lecithin-dependent hemolysin (LDH),
which had phospholipase A2/lysophospholipase activity (20),
represents a major type of hemolysin in vibrios (24). In previ-
ous work, we obtained purified recombinant V. harveyi hemo-
lysin (VHH) protein and showed that it was cytotoxic to floun-
der gill cells in tissue culture, had strong pathogenicity to
flounder when injected intraperitoneally, and had phospho-
lipase activity on egg yolk agar (26). In this study, we compared
the characteristics and activities of VHH and the null-mutant
protein of VHH obtained via site-directed mutagenesis. Also,
the type of phospholipase activity of VHH was determined by
gas chromatography (GC). Moreover, three-dimensional mod-
els were used to illustrate the properties of VHH. These stud-
ies were part of a fundamental effort to demonstrate the attack
mechanism of the hemolysin on the eukaryotic cell. Another
purpose was to obtain a nonvirulent protein usable as a com-
ponent of a potential vaccine against V. harveyi.
The amino acid sequence of VHH (translated from the
nucleotide sequence of the vhhA gene [NCBI accession num-
ber AF293430]) was submitted to a protein database (PROS-
ITE; http://www.expasy.org/prosite) to identify the motifs and
active site. The data obtained revealed that VHH might belong
to a recently discovered lipase/esterase family, i.e., the GDSL
protein family, on the basis of the presence of the conserved
active Gly-Asp-Ser-Leu motif (1, 21). To confirm this possibil-
ity, the amino acid sequence of VHH was aligned with the
sequences of known members of this enzyme family from dif-
ferent bacteria, including Escherichia coli, Pseudomonas
putida, Aeromonas hydrophila, Vibrio mimicus, V. parahaemo-
lyticus, and Xenorhabdus luminescens (1, 6, 7, 12, 16, 18, 20, 22).
The results indicated that VHH should be considered a GDSL
enzyme, based mainly on the sharing of identical invariant
residues and similar conserved sequence motifs with the pro-
teins mentioned above (data not shown). Thus, an important
residue of the GDSL motif, i.e., Ser153 in VHH, was chosen to
be replaced by a glycine, a neutral residue. The introduced
glycine was selected because as a general consideration, a
neutral residue could not have any impact on a catalytic reac-
tion, regardless of its contribution to protein conformation.
A previously constructed expression vector, pET-24d(),
plus the complete open reading frame of the vhhA gene, i.e.,
pET-24d()-vhhA (26), was used as a template for site-di-
rected PCR-based mutagenesis using a Quick Change site-
directed mutagenesis kit (Stratagene, La Jolla, CA). Mutagen-
esis primers were designed to change AGC (encoding a serine
residue) to GGC (encoding a glycine residue). The synthetic
oligonucleotides which served as primers were as follows:
5-GCA TTG GGT GAC GGC TTG TCT GAT ACA GGC
A-3 (forward) and 5-TGC CTG TAT CAG ACA AGC CGT
CAC CCA ATG C-3 (reverse) (the boldface letters indicate
the changed nucleotides). The mutation was performed ac-
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cording to the manufacturer’s specifications. The mutagenic
vhhA gene in the pET-24d() vector from a single colony was
sequenced, and the result suggested that the mutation was
introduced into the expected site and that no second-site mu-
tations were present (data not shown). Then, the plasmid of
the same clone was transformed into E. coli BL21 (Novagen,
Madison, WI) to obtain the mutant recombinant protein.
The mutant protein was overexpressed by isopropyl--D-
thiogalactopyranoside (IPTG) induction and purified by metal
chelating affinity chromatography, as previously described (26).
The concentration of the purified protein was determined to be
424 g/ml by the Bradford method (5).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
analysis was performed on a Mini-PROTEAN 3 cell apparatus
(Bio-Rad) using a 12% (wt/vol) polyacrylamide gel according
to Laemmli (10). Approximately 1 g of mutant VHH protein
was subjected to the electrophoresis. The same dose of purified
VHH protein obtained during a previous work was used as a
control. The result indicated that the expressed recombinant
protein had the same molecular weight as the native VHH
protein and was purified (data not shown).
Western blotting was performed to check the immunoreac-
tivity of the mutant VHH protein. Electrophoresis was per-
formed as described above, and then the proteins were trans-
ferred to a polyvinylidene fluoride membrane (Amersham
Biosciences, England) by use of a semidry transfer unit
(Hoefer TE70; Amersham Biosciences). Then, the membrane
was treated using a Western blotting kit (Boster, Wuhan,
China), according to the manufacturer’s instructions. An anti-
VHH antibody was prepared as previously described, and the
dilution for immunoblotting was 1:1,000 (26). The result re-
vealed that the mutant VHH protein retained an immunore-
activity against antiserum similar to that of VHH, because the
two types of proteins were subjected to electrophoresis at the
same dose and their reactions with the antiserum showed sim-
ilar levels of sensitivity by Western blotting (data not shown).
Fifty microliters of VHH (50 g/ml) and 50 l of mutant
VHH protein (50 g/ml) were added to Oxford cups, which
were placed on LB agar supplemented with 1% (vol/vol) egg
yolk (for phospholipase activity assay) or 3% (vol/vol) fish
blood cells (for hemolytic activity assay). After incubation at
37°C overnight, the presence of an opalescent zone (for phos-
pholipase assay) or a brown zone (for hemolytic assay) around
the well was considered to be evidence of a positive reaction.
The results were as follows. On the egg yolk emulsion plate,
the purified VHH formed an inner cloudy zone and an outer
distinct opalescent zone with a relative transparent ring be-
tween them. This suggested the potential multiple functions of
VHH in hydrolyzing different substrates or at least different
bonds of a single substrate, as well as the potential substrate
preferences of this protein. These possibilities were supported
to a certain extent by the results of the GC analysis. In contrast,
the purified mutant protein at the same dose as the VHH
showed no activity (Fig. 1a). On fish blood agar, the purified
VHH formed a clear brown zone, suggesting strong hemolysis.
However, the mutant protein at the same dose as the VHH
showed absolutely no activity (Fig. 1b).
According to our previous work (26), the 50% lethal dose of
the purified VHH protein was 1.2 g protein g1 fish when a
flounder was injected intraperitoneally. Moreover, purified
VHH killed all experimental animals when the dose was 6.1 g
protein g1 fish. Because the enzymatic assay indicated that
the mutant VHH protein lost all its hemolytic activity, a higher
dose, i.e., 8.0 g protein g1 fish, was used to investigate its
virulence in fish. Thus, turbot (Scophthalmus maximus) with an
average weight of 5.2 g from quarantined stocks that were
recognized as disease-free (2) were used as models to assess
pathogenicity as described below. A group of 10 turbot were
infected by intraperitoneal injection with 0.1-ml volumes of
undiluted mutant VHH protein preparations (amounting to
8.0 g protein g1 of fish). The positive controls were in-
jected with the same dose of VHH, whereas the negative con-
trols were injected with 0.1-ml volumes of Tris-buffered saline.
The infected animals were maintained for up to a week in
covered polypropylene tanks supplied with aerated seawater
(50% of the volume was changed daily) at 20°C. Dead and
moribund fish and the survivors at the end of the experiment
were examined pathologically (2). The results were as follows.
All of the fish in the positive control group injected with pu-
rified VHH died within 12 h, whereas the fish of the experi-
mental group injected with purified mutant protein and the
negative control group survived for at least a week and showed
no disease symptoms. Most infected fish of the positive control
group revealed hemorrhaging in the peritoneal cavity and
darkening of the body (i.e., melanosis), which were also the
major symptoms exhibited by the fish infected by V. harveyi
(23). The results indicated that the mutant VHH protein lost
its pathogenicity to fish. These results together with those of
the Western blotting suggested that the mutant VHH protein
might be considered as a component of a potential fish vaccine
against V. harveyi, for it was nonvirulent to fish and had an
immunoreactivity similar to that of the pathogenic VHH.
The phospholipase activity suggested that the VHH might
be a multiple-function enzyme. To investigate this point, the
type of phospholipase activity of VHH was identified by gas
chromatography. In general, the type of phospholipase was
determined according to the hydrolyzed bond of the lecithin
substrate of the enzyme. The particular free fatty acid released
by the enzyme would correspond to particular bond of the
substrate. Thereby, the enzyme type could be determined by
identification of the free fatty acids present in the enzyme-
substrate reaction medium. Hence, a special compound, a
phosphatidylcholine (lecithin) bearing two different fatty acid
FIG. 1. Results of phospholipase activity (a) and hemolytic activity
(b) tests. Mutant VHH protein lost all the enzymatic activities.
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chains, L--phosphatidyl-choline -palmitoyl -oleoyl (PCPO;
Sigma), was used as the substrate for VHH in the present study
(11). Pure oleic acid and palmitic acid served as controls. The
substrate was dissolved in 10	 reaction buffer (1.0 M Tris-HCl
[pH 8.0], 1.0% [vol/vol] Triton X-100) to a final concentration
of 5 mmol/liter. Then, 100 l of the substrate suspension was
incubated with 900 l of enzyme solution at 37°C for 2 h. The
free fatty acids present in the reaction medium were extracted
with 200 l of solvent (2:1, light petroleum-ether). After evap-
oration of the organic phase, the sample as well as pure oleic
FIG. 2. GC analysis of the hydrolytic type of the phospholipase activity of VHH. (a) Control a. The highest peak corresponds to the control oleic acid
methyl ester. (b) Control b. The highest peak corresponds to the control palmitic acid methyl ester. (c) Sample. According to the retention time of the
peaks in panels a and b, the left peak corresponds to the released palmitic acid and the right one corresponds to the released oleic acid.
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acid and palmitic acid was methylated with 3 ml of boron
trifluoride (14% [wt/vol] in methanol) for 30 min. The methyl
esters of the sample and controls were then subjected to GC
analysis, which was performed using an HP-5890II apparatus
(Hewlett Packard, Palo Alto, CA), equipped with a flame ion-
ization detector. A capillary Carbowax 20 M column (0.25-mm
inner diameter by 30 m; film thickness, 0.25 m; Ohio Valley
Speciality Co.) was used for GC with nitrogen as the carrier gas
(1 ml/min). The column was operated isothermically at 190°C,
whereas the injection port and detector were set at 250°C. The
fatty acids released by VHH from the substrate were identified
by comparison of the retention times between the peaks of the
controls and the sample (Fig. 2). The results showed that both
the oleic acid and the palmitic acid were released from PCPO
by VHH, suggesting that this enzyme was a phospholipase B or
a lysophospholipase.
Upton and Buckley (21) first classified GDSL enzymes by
the characteristic motif Gly-Asp-Ser-Leu situated near the N
terminus. These enzymes have five consensus sequences (I to
V) and four invariant important catalytic residues, namely Ser,
Gly, Asn, and His in blocks I, II, III, and V, respectively, which
led to a new designation of these enzymes as the SGNH-
hydrolase family. The serine residue in block I, which was also
located at the active GDSL motif, was usually considered to be
an important member of the active site. Hence, to obtain a
null-mutant protein of VHH by introducing one or more mu-
tations, the corresponding residue of VHH, i.e., Ser153, was
chosen for the first mutagenesis operation. However, it was
interesting that a single residue change led to the loss of all of
VHH’s hemolytic and phospholipase activities and its patho-
genicity to fish. To explain this, we turned to the steric struc-
ture of the active site and action mode of GDSL enzymes.
Based on (i) the description by Akoh et al. (1) of the hy-
pothesis of the catalytic mechanism of SGNH-hydrolases
which had substantial crystallographic evidence, (ii) the action
mode of the catalytic triad in the serine proteases which shares
a mechanism of action similar to that of the GDSL enzymes,
and (iii) the relative positions of the conserved active residues
of a representative GDSL enzyme, thioesterase I from E. coli,
revealed by the three-dimensional model constructed with
published coordinate data from the Protein Data Bank (Fig.
3), we concluded that the active site of GDSL enzymes con-
sisted of two subgroups of residues, each containing three
conserved members, irrespective of the residues of the sub-
strate-binding site. One subgroup involved the Ser residue in
block I, the Gly residue in block II, and Asn in block III. They
constituted the so-called “oxyanion hole.” The other subgroup
included the Ser in block I and the His in block V, as well as
another conserved residue, Asp, also in block V and the third
amino acid preceding His. These residue subgroups composed
the catalytic triad, which had the same residues in the serine
proteases. The members of each subgroup formed a triangle in
the steric structure. Moreover, two triangles shared a common
vertex, i.e., the active Ser residue in block I (Fig. 3). Each of
the five residues described above played a key role in the
function of the enzyme. Furthermore, it was proposed that the
Ser in block I served as the nucleophile. The hydroxyl group
was deprotonated by the His residue in block V to make the
Ser more nucleophilic, which resulted in the formation of a
tetrahedral oxyanion in a transition state. The protonated His
was stabilized by the third member of the catalytic triad, the
Asp in block V. As to the oxyanion hole, the amide protons of
the Ser in block I and the Gly in block II, together with the H

of the Asn in block III, served as the proton donors of the
oxyanion hole that stabilized the tetrahedral intermediate.
On the basis of the active-site features and action mode of
the GDSL enzymes, we found that the active serine of the
GDSL motif is the center residue of the active site and acts as
the main “performer” in the catalytic reaction, with the assis-
tance of other key residues. Hence, it was understandable that
the replacement of Ser153 in VHH resulted in the loss of all
the functions examined.
In conclusion, V. harveyi hemolysin was demonstrated to be
a lysophospholipase or a phospholipase B. A particular single
base change introduced by the substitution of a glycine for
Ser153 resulted in the loss of the hemolytic and phospholipase
activities of VHH as well as its pathogenicity to fish. Since the
mutant protein was purified and proved to have an immuno-
reactivity similar to that of VHH, this mutant protein might be
considered as a component of a potential vaccine against V.
harveyi. This study of TLH-like hemolysin is the first to provide
FIG. 3. Key residues of the active site in GDSL enzymes. A three-
dimensional model of a representative GDSL enzyme, thioesterase I
from E. coli, was generated with structural information available in the
Protein Data Bank to illustrate the basic residues of the catalytic triad
and oxyanion hole in an SGNH hydrolase. Ser10, Gly44, Asn73,
Asp154, and His157 in this protein corresponded to the residues Ser,
Gly, Asn, and His in blocks I, II, III, and V of a general GDSL enzyme,
respectively. The alpha carbon atoms of these residues are linked with
dark lines to show their relative positions. The figure was drawn using
a WebLab Viewer (Accelrys, Cambridge, United Kingdom).
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substantial experimental data to support the hypothesis on the
mechanism of action of GDSL enzymes. Moreover, the fact
that disruption of the active site of phospholipase activity of
VHH resulted in the loss of hemolytic activity and pathoge-
nicity to fish suggests that the phospholipase activity of VHH
probably plays a major role in hemolysis.
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